GENEVA, Oct. 9 -- ASTELLAS PHARMA INC. filed a patent application (JP2026/013094) for “5'-CAP COMPOUND FOR USE IN RNA”. With publication no. WO/2026/211723, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07F 9/6561
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....